Invention Grant
- Patent Title: Modified fluorinated nucleoside analogues
- Patent Title (中): 改性氟化核苷类似物
-
Application No.: US12878262Application Date: 2010-09-09
-
Publication No.: US08415322B2Publication Date: 2013-04-09
- Inventor: Jeremy Clark
- Applicant: Jeremy Clark
- Applicant Address: US NJ Princeton
- Assignee: Gilead Pharmasset LLC
- Current Assignee: Gilead Pharmasset LLC
- Current Assignee Address: US NJ Princeton
- Agency: Fitzpatrick, Cella, Harper & Scinto
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70

Abstract:
The disclosed invention provides compositions and methods of treating a Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and a rhinovirus infection in a host, including animals, and especially humans, using a (2′R)-2′-deoxy-2′-fluoro-2′-C-methyl nucleosides, or a pharmaceutically acceptable salt or prodrug thereof.
Public/Granted literature
- US20110038833A1 MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES Public/Granted day:2011-02-17
Information query
IPC分类: